GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types.
Philipp SieversDamian StichelMartin SillDaniel SchrimpfDominik SturmFlorian SeltJonas EckerDaniel KazdalEvelina MieleMariëtte E G KranendonkBastiaan B J TopsPatricia Kohlhof-MeineckeRudi BeschornerChristof M KrammMartin HasselblattGuido ReifenbergerDavid CapperPieter WesselingAlbrecht StenzingerTill MildeAndrey KorshunovOlaf WittStefan M PfisterWolfgang WickAndreas von DeimlingDavid T W JonesFelix SahmPublished in: Acta neuropathologica (2021)